tetramethylpyrazine has been researched along with Kidney Failure, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosuru, R; Prakash, S; Rai, U; Singh, S; Tiwari, V | 1 |
| Cao, WF; Chen, BX; Li, RH | 1 |
1 review(s) available for tetramethylpyrazine and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Status quo of experimental and clinical studies in retarding kidney damage of chronic nephropathy by ligustrazine].
Topics: Animals; Calcium Channel Blockers; Free Radical Scavengers; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Pyrazines | 1997 |
1 other study(ies) available for tetramethylpyrazine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Kidney; Kidney Failure, Chronic; Male; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Wistar; Signal Transduction | 2019 |